Clinical and Cost-Effectiveness of Outpatient Strategies for Management of Febrile Infants
1 From the Robert Wood Johnson Clinical Scholars Program, University of California, San Francisco; Pediatrics, School of Medicine, the Health Care Systems Department, the Wharton School, Philadelphia, PA
2 From the Division of Emergency Medicine, Department of Medicine, Harvard Medical School, Boston, MA
3 From the Department of Medicine (Section of General Internal Medicine and Clinical Epidemiology Unit), School of Medicine, the Health Care Systems Department, the Wharton School, Philadelphia, PA; and the Leonard Davis Institute of Health Care Economics, University of Pennsylvania, Philadelphia
Young infants with fever are at risk for serious bacterial infection, but no consensus exists on the optimal approach to diagnosis and treatment. Although the traditional recommendation is always to perform all sepsis tests, including lumbar puncture, and administer intravenous (IV) antibiotics until culture results are negative, recent studies suggest administering intramuscular (IM) ceftriaxone with outpatient follow-up or using laboratory and clinical data to exclude low-risk patients from hospitalization, further testing, and antibiotic treatment. A decision analysis model was used to evaluate six strategies for the diagnosis and treatment of infants aged 28 to 90 days with temperature
38.0°C. Data from the literature, data from a 1991 study of 503 febrile infants, and direct, short-term costs from the Children's Hospital of Philadelphia were used as model inputs. The model was run for a hypothetical cohort of 100 000 febrile infants who did not require admission for focal infection or for other reasons that clearly necessitated admission. The model included six strategies: (1) no intervention; (2) all sepsis tests (lumbar puncture, blood culture, urine culture, white blood cell count, and urinalysis) followed by hospitalization and IV antibiotics for all infants; (3) all sepsis tests followed by IM ceftriaxone and outpatient management for most infants; (4) blood and urine cultures with white blood cell count and urinalysis followed by either lumbar puncture and IV antibiotics for high-risk infants or outpatient management without antibiotics for low-risk infants; (5) white blood cell count and urinalysis followed by either lumbar puncture, blood and urine cultures, and IV antibiotics for high-risk infants or outpatient management without antibiotics for low risk infants; and (6) clinical judgment followed by either all sepsis tests and IV antibiotics for high-risk infants or outpatient management without antibiotics for low-risk infants. The two "all sepsis tests" strategies prevented the most cases of death or neurologic impairment, 78% (when IV antibiotics were used) and 76% (when IM ceftriaxone was used) of all potential cases. The most cost-effective strategy was to use all sepsis tests followed by IM ceftriaxone for all patients without meningitis, at an incremental cost of only $3900 per sequela prevented relative to no intervention. Strategies under which only those patients selected as high-risk by laboratory criteria received antibiotic treatment were less effective but incurred lower rates of antibiotic complications. Clinical judgment alone was the least clinically effective and the second least cost-effective strategy. The model's results depended most on assumptions about the effectiveness of IM ceftriaxone, the sensitivity of the white blood cell count, and the sensitivity of clinical judgment in identifying young infants with serious bacterial infection. Combining all sepsis tests with IM ceftriaxone has superior clinical and cost-effectiveness compared with other strategies for managing febrile infants in this model. Strategies that use selective antibiotic treatment based on laboratory tests or clinical judgment are acceptable when the sensitivity of the criterion used is high, but they do not surpass strategies that combine all sepsis tests and antibiotic treatment until the criterion's sensitivity is greater than 96%.
Key Words: fever outpatient treatment infants cost
Submitted on June 17, 1991
Accepted on November 18, 1991
This article has been cited by other articles:
![]() |
N. Kuppermann Diagnostic Testing of the Febrile Neonate: It Is Time to Collaborate Arch Pediatr Adolesc Med, June 1, 2003; 157(6): 508 - 509. [Full Text] [PDF] |
||||
![]() |
J. C. Brown, J. L. Burns, and P. Cummings Ampicillin Use in Infant Fever: A Systematic Review Arch Pediatr Adolesc Med, January 1, 2002; 156(1): 27 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Bachur and M. B. Harper Predictive Model for Serious Bacterial Infections Among Infants Younger Than 3 Months of Age Pediatrics, August 1, 2001; 108(2): 311 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Kaplan, M. B. Harper, M. N. Baskin, A. B. Macone, and K. D. Mandl Time to Detection of Positive Cultures in 28- to 90-Day-Old Febrile Infants Pediatrics, December 1, 2000; 106(6): 74e - 74. [Abstract] [Full Text] |
||||
![]() |
K. L. McGowan, J. A. Foster, and S. E. Coffin Outpatient Pediatric Blood Cultures: Time to Positivity Pediatrics, August 1, 2000; 106(2): 251 - 255. [Abstract] [Full Text] |
||||
![]() |
M. D. Baker and L. M. Bell Unpredictability of Serious Bacterial Illness in Febrile Infants From Birth to 1 Month of Age Arch Pediatr Adolesc Med, May 1, 1999; 153(5): 508 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Baker, L. M. Bell, and J. R. Avner The Efficacy of Routine Outpatient Management Without Antibiotics of Fever in Selected Infants Pediatrics, March 1, 1999; 103(3): 627 - 631. [Abstract] [Full Text] |
||||
![]() |
P W Fowlie and B Schmidt Diagnostic tests for bacterial infection from birth to 90 days---a systematic review Arch. Dis. Child. Fetal Neonatal Ed., March 1, 1998; 78(2): 92F - 98. [Abstract] [Full Text] |
||||
![]() |
M. D. Baker, L. M. Bell, and J. R. Avner Outpatient Management without Antibiotics of Fever in Selected Infants N. Engl. J. Med., November 11, 1993; 329(20): 1437 - 1441. [Abstract] [Full Text] |
||||








